Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | Director | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,527 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Exercise / conversion · Acquired 668 · Balance 15,527 |
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2036-06-01 | Direct | 5,772 |
Reported balance
After 2026-06-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-01 · Grant · Acquired 5,772 · Balance 5,772 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. |
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2035-06-02 | Direct | 0 |
Reported balance
After 2026-06-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-02 · Exercise / conversion · Disposed 668 · Balance 0 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 3, 2026 20:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 668 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000069 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 668 shares Expires 2035-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 668 | $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000069 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:12 UTC | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 5,772 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000069 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,772 Underlying: Common Stock · 5,772 shares Expires 2036-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 15:06 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 897 | $53.51 | $48,000.26 |
DisclosureSEC source: 0000816956-25-000042 · form4.xml · nonDerivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,859 Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 15:06 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,103 | $53.54 | $59,049.11 |
DisclosureSEC source: 0000816956-25-000042 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,756 Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 21:35 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016762 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 479 shares Expires 2034-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 21:35 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 479 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016762 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 21:35 UTC | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 668 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016762 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 668 Underlying: Common Stock · 668 shares Expires 2035-06-02 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 21:35 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 8,061 | $0.00 Strike: $55.38 | $0.00 |
DisclosureSEC source: 0001127602-25-016762 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,061 Underlying: Common Stock · 8,061 shares Expires 2035-06-02 F1 · derivative.exercise_date: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period. Read SEC document |
| May 29, 2025 Filed May 30, 2025 21:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSARs (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $55.70 | $0.00 |
DisclosureSEC source: 0001127602-25-016068 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. Read SEC document |
| May 29, 2025 Filed May 30, 2025 21:12 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 966 | $57.69 | $55,728.54 |
DisclosureSEC source: 0001127602-25-016068 · form4.xml · nonDerivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,380 Read SEC document |
| May 29, 2025 Filed May 30, 2025 21:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $55.70 | $55,700.00 |
DisclosureSEC source: 0001127602-25-016068 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2025 Filed May 6, 2025 20:07 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 4,000 | $56.94 | $227,768.00 |
DisclosureSEC source: 0001127602-25-013471 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,346 Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 14:46 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSARs (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001127602-24-023639 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2024-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs vesting on June 1, 2015 and expiring on September 11, 2024. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 14:46 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 534 | $74.31 | $39,681.54 |
DisclosureSEC source: 0001127602-24-023639 · form4.xml · nonDerivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,346 Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 14:46 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $39.64 | $39,640.00 |
DisclosureSEC source: 0001127602-24-023639 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:09 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017849 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:09 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017849 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:09 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017849 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:09 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017849 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:37 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017622 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:37 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017622 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:37 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017622 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:37 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017622 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:20 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016538 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:20 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016538 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016538 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016538 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:13 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018898 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:13 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018898 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018898 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018898 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:31 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018660 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:31 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018660 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:31 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018660 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:31 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018660 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:00 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020747 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:00 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020747 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020747 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020747 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:12 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,549 | $0.00 Strike: $69.03 | $0.00 |
DisclosureSEC source: 0001127602-18-019812 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,549 Underlying: Common Stock · 2,549 shares Expires 2028-06-01 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:12 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019812 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,629 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019812 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires 2027-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019812 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 18:31 UTC | CONMED Corp CNMD · Entity 4691 | PurchaseCommon Stock | 158 | $50.61 | $7,996.38 |
DisclosureSEC source: 0001127602-18-000983 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,707 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 27, 2017. Read SEC document |
| October 03, 2017 Filed Oct 3, 2017 21:21 UTC | CONMED Corp CNMD · Entity 4691 | PurchaseCommon Stock | 148 | $53.96 | $7,986.08 |
DisclosureSEC source: 0001127602-17-029013 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,549 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 27, 2017. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 16:05 UTC | CONMED Corp CNMD · Entity 4691 | PurchaseCommon Stock | 157 | $50.78 | $7,972.46 |
DisclosureSEC source: 0001127602-17-023244 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,401 F1 · price: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 27, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:32 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 3,669 | $51.90 Strike: $51.90 | $190,421.10 |
DisclosureSEC source: 0001127602-17-020267 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,669 Underlying: Common Stock · 3,669 shares Expires 2027-06-01 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:32 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 2,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020267 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,167 Underlying: Common Stock · 2,167 shares Expires 2027-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,739 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020267 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,739 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.